The 20 Best Juvenile Primary Osteoporosis Doctors Near Me in Brighton, MI

Dr Scowden grew up just outside of Flint MI and was very pleased to return “home” after completing training. In addition to her primary role of patient care, she also works with our resident physicians longitudinally during their internal medicine training as well as hosts medical students for their internal medicine rotations. She has three children and loves her dogs as if they were human children as well! When not working or parenting, she is likely to be reading, working outside on some project or another, or spending time with family. Dr. Scowden is rated as an Experienced provider by MediFind in the treatment of Juvenile Primary Osteoporosis. Her top areas of expertise are Hypertension, Glucocorticoid-Remediable Aldosteronism, Familial Hypertension, and Type 2 Diabetes (T2D).

Kara Mizokami-Stout, MD, MSc is an Assistant Professor of Internal Medicine with an appointment in the Division of Metabolism, Endocrinology, and Diabetes. She attended medical school and internal medicine residency at the University of Colorado. She then completed her endocrinology fellowship at the University of Michigan. She joined the faculty at the University of Michigan in 2017 and has a dual appointment at the Ann Arbor VA.Dr. Mizokami-Stout’s practice focuses on type 1 diabetes, type 2 diabetes, and general endocrinology. She also conducts health services research in the field of diabetes. Dr. Mizokami is rated as an Experienced provider by MediFind in the treatment of Juvenile Primary Osteoporosis. Her top areas of expertise are Diabetic Neuropathy, Type 1 Diabetes (T1D), Type 2 Diabetes (T2D), and Graves Disease.

David T. Broome, MD, is a Clinical Assistant Professor of Medicine in the Metabolism, Endocrinology, and Diabetes (MEND) Division of the University of Michigan. Dr. Broome's clinical and research interests are in Type 1 Diabetes Mellitus, Atypical Diabetes and Monogenic Diabetes (including MODY), Type 2 Diabetes Mellitus, Hypoglycemia, Thyroid Cancer and Primary Hyperparathyroidism. Dr. Broome is dedicated to progress in scholarly work, translational research, and was the recipient of the Tait Endowed Research Scholarship for his work in diabetes in medical school, selected to the Clinical Scholars Program in residency, and several research and teaching thereafter, including: the Cleveland Clinic Foundation Endocrinology & Metabolism Institute Research Award, ENDO Experience Travel Award, the Cleveland Clinic Lerner College of Medicine Excellence in Teaching Award, the AACE Domestic Resident Travel Grant, and most recently the Michigan Clinical Trials Academy. Dr. Broome currently serves as a Review Editor on the editorial board for Frontiers in Clinical Diabetes and Healthcare. In his free time, Dr. Broome enjoys ice hockey, cycling, and spending time with family and friends on the beach in Holland, MI. Dr. Broome is rated as an Experienced provider by MediFind in the treatment of Juvenile Primary Osteoporosis. His top areas of expertise are Familial Partial Lipodystrophy, Type 2 Diabetes (T2D), Type 1 Diabetes (T1D), Gestational Diabetes, and Parathyroidectomy.

Kathleen Kemmer is a Hematologist and an Oncologist in Brighton, Michigan. Dr. Kemmer is rated as an Experienced provider by MediFind in the treatment of Juvenile Primary Osteoporosis. Her top areas of expertise are Breast Cancer, Paget Disease of the Breast, HER-2 Positive Breast Cancer, and Angiosarcoma.

Inocencio Cuesta is an Internal Medicine specialist and a Rheumatologist in Brighton, Michigan. Dr. Cuesta is rated as an Experienced provider by MediFind in the treatment of Juvenile Primary Osteoporosis. His top areas of expertise are Postmenopausal Osteoporosis, Osteoporosis, Rheumatoid Arthritis (RA), and Systemic Lupus Erythematosus (SLE).

Nada Fanous is an Internal Medicine specialist and an Endocrinologist in Brighton, Michigan. Dr. Fanous is rated as an Experienced provider by MediFind in the treatment of Juvenile Primary Osteoporosis. Her top areas of expertise are Type 1 Diabetes (T1D), Type 2 Diabetes (T2D), Hashimoto Thyroiditis, and Hyperparathyroidism.

James Dowd is a Rheumatologist in Brighton, Michigan. Dr. Dowd is rated as an Experienced provider by MediFind in the treatment of Juvenile Primary Osteoporosis. His top areas of expertise are Rheumatoid Arthritis (RA), Fibromyalgia, Vitamin D Deficiency, and Gout.

Mary Rupp is a primary care provider, practicing in Family Medicine in Brighton, Michigan. Dr. Rupp is rated as an Experienced provider by MediFind in the treatment of Juvenile Primary Osteoporosis. Her top areas of expertise are Primary Biliary Cholangitis, Reynolds Syndrome, Familial Hypertension, and Hypertension.

Liselle Douyon is an Internal Medicine specialist and an Endocrinologist in Ann Arbor, Michigan. Dr. Douyon is rated as a Distinguished provider by MediFind in the treatment of Juvenile Primary Osteoporosis. Her top areas of expertise are Postmenopausal Osteoporosis, Osteoporosis, Thyroid Nodule, and Juvenile Primary Osteoporosis.

Cristina Nieves is an Internal Medicine specialist and an Endocrinologist in Ann Arbor, Michigan. Dr. Nieves is rated as an Advanced provider by MediFind in the treatment of Juvenile Primary Osteoporosis. Her top areas of expertise are Toxic Nodular Goiter, Thyroid Storm, Type 2 Diabetes (T2D), and Low Blood Sugar.

Dr. Gregory Clines is an Associate Professor of Internal Medicine in the Division of Metabolism, Endocrinology & Diabetes (MEND) at the University of Michigan. He received his MD and PhD degrees at the University of Texas Southwestern Medical Center at Dallas. He then completed internal medicine training at Duke University and an endocrinology fellowship at the University of Virginia. Before joining the University of Michigan in 2013, he was on the faculty at the University of Virginia and the University of Alabama at Birmingham.Dr. Clines has been studying and thinking about bone diseases for nearly 30 years. His basic science laboratory studies how novel factors such as hypoxia, androgens, endothelins, Wnt signaling, and other factors regulate the osteoblast-cancer cell synergy in bone metastasis. His other research interests include understanding how sex steroids regulate skeletal size and shape, and the development of novel imaging techniques to assess bone quality.His clinical interests include metabolic and genetic bone diseases as well as general endocrinology. Dr. Clines sees patients at the Metabolism, Endocrinology & Diabetes Clinic (Metabolic Bone Disease Clinic) and at the Ann Arbor Veterans Affairs Medical Center. Dr. Clines is rated as an Advanced provider by MediFind in the treatment of Juvenile Primary Osteoporosis. His top areas of expertise are Osteoporosis, Paget's Disease of Bone, Postmenopausal Osteoporosis, Orchiectomy, and Parathyroidectomy.

Preethi Gogineni is an Internal Medicine specialist and an Endocrinologist in Ann Arbor, Michigan. Dr. Gogineni is rated as an Advanced provider by MediFind in the treatment of Juvenile Primary Osteoporosis. Her top areas of expertise are Hyperparathyroidism, Type 1 Diabetes (T1D), Gestational Diabetes, and Osteoporosis.

Sobia Raja is an Internal Medicine specialist and an Endocrinologist in Ann Arbor, Michigan. Dr. Raja is rated as an Experienced provider by MediFind in the treatment of Juvenile Primary Osteoporosis. Her top areas of expertise are Osteoporosis, Thyroid Nodule, Hypoaldosteronism, Endoscopy, and Hip Replacement.

Farah Daneshvar, DO is a Clinical Assistant Professor in the Division of Metabolism, Endocrinology and Diabetes. Dr. Daneshvar received her bachelor's degree from University of Michgian (Ann Arbor, MI) and her medical degree from Michigan State University (Lansing, MI). She completed both her internal medicine residency and chief residency at Sinai Grace Hospital/Detroit Medical Center (Detroit, MI) and then underwent fellowship training in endocrinology at the University of Washington (Seattle, WA).Dr. Daneshvar is involved in medical eduation including medical students, residents, and fellows. She is the preceptor for Fellows’ Clinic for Endocrinology Fellowship Program at the University of Michigan. Dr. Daneshvar is rated as an Experienced provider by MediFind in the treatment of Juvenile Primary Osteoporosis. Her top areas of expertise are Type 2 Diabetes (T2D), Pituitary Tumor, Prolactinoma, and Exogenous Cushing's syndrome.

Zahrae Sandouk M.D., is a Clinical Assistant Professor, board certified in Internal Medicine and Endocrinology, Diabetes & Metabolism and a graduate from Henry Ford Hospital and Cleveland Clinic who has an interest in Diabetes mellitus, Diabetes complications, Cystic Fibrosis related Diabetes, Pituitary disorders, Prolactinoma, Hypopituitarism, Thyroid disorders, Bone and calcium disorders, Adrenal and Osteoporosis. Also the medical director of the Endocrine Testing Unity at the University of Michigan where dynamic studies are performed and is also part of the Cystic Fibrosis multidisciplinary team. Dr. Sandouk is rated as an Experienced provider by MediFind in the treatment of Juvenile Primary Osteoporosis. Her top areas of expertise are Type 1 Diabetes (T1D), Adrenal Insufficiency Pediatric, Type 2 Diabetes (T2D), and Thyroid Nodule.

Nevin Ajluni, M.D., joined the team at the Division of Metabolism, Endocrinology & Diabetes (MEND) after serving a two-year endocrinology fellowship in the Division. She is a part of the care team in the MEND Weight Management Program, where she works with obese individuals by applying cutting-edge research findings and novel clinical strategies. She is an honors graduate of the Wayne State University School of Medicine and completed her internship and residency in internal medicine at the McGaw Medical Center of Northwestern University before coming to the University of Michigan. Dr. Ajluni is rated as an Experienced provider by MediFind in the treatment of Juvenile Primary Osteoporosis. Her top areas of expertise are Type 1 Diabetes (T1D), Familial Partial Lipodystrophy, Congenital Generalized Lipodystrophy, and Type 2 Diabetes (T2D).

Daniyeh Khurram is an Internal Medicine specialist and an Endocrinologist in Ann Arbor, Michigan. Dr. Khurram is rated as an Experienced provider by MediFind in the treatment of Juvenile Primary Osteoporosis. Her top areas of expertise are Hyperparathyroidism, Osteitis Fibrosa, Neonatal Severe Hyperparathyroidism, Thrombectomy, and Endoscopy.

Merve Kutahyalioglu M.D., is a Clinical Assistant Professor in the Division of Metabolism, Endocrinology, and Diabetes. She completed her internal medicine internship and residency at the University of Texas Health Science Center, and endocrinology fellowship training at the Baylor College of Medicine. She is board certified in Internal Medicine and Endocrinology, Diabetes & Metabolism. Dr. Kutahyalioglu joined the faculty at the University of Michigan in 2021. She has an interest in general endocrinology. She is a part of the care team in the MEND Weight Management and MEND Post-Bariatric Surgery Care Program. Dr. Kutahyalioglu is rated as an Experienced provider by MediFind in the treatment of Juvenile Primary Osteoporosis. Her top areas of expertise are Malnutrition, Type 1 Diabetes (T1D), Obesity in Children, and Hyperparathyroidism.

Dr. Chun is a physician-scientist, who practices general endocrinology, including diabetes, thyroid diseases, and metabolic syndrome. His research is focused on the cellular and molecular mechanism of obesity, diabetes, and inflammatory and fibrotic tissue damages in endocrine disorders, such as Graves’ eye disease. Dr. Chun is rated as an Experienced provider by MediFind in the treatment of Juvenile Primary Osteoporosis. His top areas of expertise are Hyperparathyroidism, Familial Isolated Hyperparathyroidism, Parathyroid Hyperplasia, and Osteitis Fibrosa.

Maria Papaleontiou, MD, is an Associate Professor of Internal Medicine with an appointment in the Division of Metabolism, Endocrinology and Diabetes, and a Research Associate Professor at the Institute of Gerontology, at the University of Michigan. Prior to starting her internal medicine residency at Saint Peter's University Hospital in New Jersey, she spent several years conducting clinical research on aging at Weill Cornell Medical College in New York City. She completed her endocrinology fellowship at the University of Michigan, where she subsequently joined the faculty in 2013. She is a recipient of Fulbright and Howard Hughes Medical Institute scholarships. Her clinical practice focuses on thyroid diseases and thyroid cancer, as well as geriatric endocrinology.Dr. Papaleontiou is also a health services researcher in the field of thyroidology and aging. Her research focuses on evaluating the risks of thyroid hormone overtreatment and misuse in older adults, understanding the role of providers and patients in thyroid hormone use and misuse and how it relates to patient outcomes in the aging population, as well as the role of age and comorbidity in thyroid cancer decision-making. Her ultimate goal is to develop tools to tailor thyroid disease treatment to older adults by translating research findings into effective strategies and interventions to improve the care of older adults and reduce patient harm. She has received funding from the National Institute on Aging, the Claude D. Pepper Older American Independence Centers, the University of Michigan Biology of Cardiovascular Aging Core and the Elizabeth Caroline Crosby Research Award. She serves on multiple national committees including at the American Thyroid Association (ATA), the Endocrine Society, the American Association of Clinical Endocrinology and the North American Society for Interventional Thyroidology. She has served as Co-Chair for the ATA’s Annual Program Committee (2021-2022), Chair of the ATA’s Women in Thyroidology (2022-2023) and Vice-Chair for AACE's Thyroid Disease State Network (2022-2023). She is an Associate Editor for Endocrine Practice, and serves on the Editorial Boards for Thyroid and BMC Endocrine Disorders. Dr. Papaleontiou is rated as an Experienced provider by MediFind in the treatment of Juvenile Primary Osteoporosis. Her top areas of expertise are Thyroid Cancer, Thyroid Nodule, Hypothyroidism, Thyroidectomy, and Hormone Replacement Therapy (HRT).